ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

Gore Proposes New War On cancer, Double research Funding Over 5 years

July 9, 1999

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Former kidney cancer advocate Carl Dixon charged with theft of $335,000 from association.

October 3, 2003

Brain Tumor Research Needs Stronger Interdisciplinary Collaboration, PRG Says.

November 17, 2000